| Net Cash Provided by (Used in) Operating Activities |
$1,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$13,213,000 |
USD |
-79% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$7,166,000 |
USD |
88% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2,200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
149,051 |
shares |
155% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,893,000 |
USD |
609% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$63,565,000 |
USD |
8.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$2,336,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$19,725,000 |
USD |
3083% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$13,896,872 |
USD |
210% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |